$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 11, 2025)
$55.72M
Market Cap
-
P/E Ratio
-1.62
EPS
$2.99
52 Week High
$0.87
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Adlai Nortye Ltd. is a clinical-stage biotechnology company focused on the research and development of innovative cancer therapies, primarily targeting opportunities in the United States and Mainland China. Headquartered in Grand Cayman, the firm is committed to leveraging cutting-edge scientific methodologies to meet significant unmet medical needs in oncology. With a strong and diverse pipeline, Adlai Nortye is strategically positioned to make a meaningful impact in the cancer treatment landscape, paving the way for potential collaborations and partnerships within the biopharmaceutical industry.
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
KVUE
TSLA
ADAP
DNN
AAL
AVGO
HOOD
MARA
NFLX
WBD
GOOGL
SOFI
RR
VALE
NIO
T
RGTI
BYND
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RKLB
QBTS
RIG
JBLU
AMD
CIFR
AG
CDE
SNAP
MTSR
BTBT
NCLH
IREN
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
UBER
SMCI
KO
WULF
LUV
SOUN
SMR
CNQ
VZ
CLSK
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
KVUE
TSLA
ADAP
DNN
AAL
AVGO
HOOD
MARA
NFLX
WBD
GOOGL
SOFI
RR
VALE
NIO
T
RGTI
BYND
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RKLB
QBTS
RIG
JBLU
AMD
CIFR
AG
CDE
SNAP
MTSR
BTBT
NCLH
IREN
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
UBER
SMCI
KO
WULF
LUV
SOUN
SMR
CNQ
VZ
CLSK